Search results for "gene editing"
showing 10 items of 20 documents
The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated cha…
2019
The recent progress in genetic engineering has brought multiple benefits to the food and agricultural industry by enhancing the essential characteristics of agronomic traits. Powerful tools in the field of genome editing, such as siRNA-mediated RNA interference for targeted suppression of gene expression and transcription activator-like effector nucleases (TALENs) and zinc-finger nucleases (ZFNs) for DNA repair have been widely used for commercial purposes. However, in the last few years, the discovery of the CRISPR-Cas9 system has revolutionized genome editing and has attracted attention as a powerful tool for several industrial applications. Herein, we review current progresses in the uti…
Engineering CRISPR guide RNA riboswitches for in vivo applications
2019
CRISPR-based genome editing provides a simple and scalable toolbox for a variety of therapeutic and biotechnology applications. Whilst the fundamental properties of CRISPR proved easily transferable from the native prokaryotic hosts to eukaryotic and multicellular organisms, the tight control of the CRISPR-editing activity remains a major challenge. Here we summarise recent developments of CRISPR and riboswitch technologies and recommend novel functionalised synthetic-gRNA (sgRNA) designs to achieve inducible and spatiotemporal regulation of CRISPR-based genetic editors in response to cellular or extracellular stimuli. We believe that future advances of these tools will have major implicati…
Phosphorylation of CENP-A on serine 7 does not control centromere function.
2019
CENP-A is the histone H3 variant necessary to specify the location of all eukaryotic centromeres via its CENP-A targeting domain and either one of its terminal regions. In humans, several post-translational modifications occur on CENP-A, but their role in centromere function remains controversial. One of these modifications of CENP-A, phosphorylation on serine 7, has been proposed to control centromere assembly and function. Here, using gene targeting at both endogenous CENP-A alleles and gene replacement in human cells, we demonstrate that a CENP-A variant that cannot be phosphorylated at serine 7 maintains correct CENP-C recruitment, faithful chromosome segregation and long-term cell viab…
Anti-ageing gene therapy: Not so far away?
2019
Improving healthspan is the main objective of anti-ageing research. Currently, innovative gene therapy-based approaches seem to be among the most promising for preventing and treating chronic polygenic pathologies, including age-related ones. The gene-based therapy allows to modulate the genome architecture using both direct (e.g., by gene editing) and indirect (e.g., by viral or non-viral vectors) approaches. Nevertheless, considering the extraordinary complexity of processes involved in ageing and ageing-related diseases, the effectiveness of these therapeutic options is often unsatisfactory and limited by their side-effects. Thus, clinical implementation of such applications is certainly…
A Comparison of Techniques to Evaluate the Effectiveness of Genome Editing
2018
Genome editing using engineered nucleases (meganucleases, zinc finger nucleases, transcription activator-like effector nucleases) has created many recent breakthroughs. Prescreening for efficiency and specificity is a critical step prior to using any newly designed genome editing tool for experimental purposes. The current standard screening methods of evaluation are based on DNA sequencing or use mismatch-sensitive endonucleases. They can be time-consuming and costly or lack reproducibility. Here, we review and critically compare standard techniques with those more recently developed in terms of reliability, time, cost, and ease of use.
Comparison of CRISPR and Marker-Based Methods for the Engineering of Phage T7
2020
This article belongs to the Section Bacterial Viruses.
Modulação gênica em embriões humanos
2018
O recente implemento de moderna tecnologia -CRISPR/Cas9- possibilitou o avanço inquestionável da edição gênica em linhagem germinativa humana, seja por meio da manipulação de células precursoras de gametas, células tronco pluripotentes, gametas ou, até mesmo, de embriões. Mesmo levando em conta os benefícios terapêuticos preventivos demonstrados nas pesquisas básicas e préclínicas em embriões humanos, tais investigações encontram barreiras de aceitação em todo o mundo. Tal situação exige mudança de atitude no sentido de incrementar o debate em torno da aplicabilidade dessas novas tecnologias. Assim, a adequação das atuais regulamentações faz-se necessária e deve incluir a superação dos desa…
Dimēriskas dCas9-FokI sistēmas izveidošana efektīvai zīdītāju šūnu genoma rekombinēšanai
2015
CRISPR/Cas9 sistēma nodrošina robustu un plaši pielietojamu genoma rekombinēšanas tehnoloģiju, kas paver iespēju zinātniekiem precīzi manipulēt ar specifickiem genoma elementiem, ko izmantot gēnu funkciju pētījumos bioloģijā un slimību attīstībā. Darba mērķis bija izveidot un optimizēt dCas9-FokI sistēmu, kas nodrošinātu stabilu un specifisku genoma rekombinēšanu cilvēka šūnās. Mēs piedāvājam alternatīvu tehnoloģiju, kas ir balstīta uz RNS vadītu dCas9-FokI sistēmu un piedāvā ievērojamu genoma rekombinēšanas potenciālu ar samazinātu nespecifiskās šķelšanas (off-targeting) efektu. Iegūtie dati liecina, ka šī izveidotā sistēma var tikt efektīvi izmantota genoma rekombinēšanai zīdītāju šūnās. …
Nucleotide excision repair of abasic DNA lesions
2019
AbstractApurinic/apyrimidinic (AP) sites are a class of highly mutagenic and toxic DNA lesions arising in the genome from a number of exogenous and endogenous sources. Repair of AP lesions takes place predominantly by the base excision pathway (BER). However, among chemically heterogeneous AP lesions formed in DNA, some are resistant to the endonuclease APE1 and thus refractory to BER. Here, we employed two types of reporter constructs accommodating synthetic APE1-resistant AP lesions to investigate the auxiliary repair mechanisms in human cells. By combined analyses of recovery of the transcription rate and suppression of transcriptional mutagenesis at specifically positioned AP lesions, w…
Improvement of baculovirus as protein expression vector and as biopesticide by CRISPR/Cas9 editing
2019
The clustered regularly interspaced short palindromic repeats (CRISPR) system?associated Cas9 endonuclease is a molecular tool that enables specific sequence editing with high efficiency. In this study, we have explored the use of CRISPR/Cas9 system for the engineering of baculovirus. We have shown that the delivering of Cas9-single guide RNA ribonucleoprotein (RNP) complex with or without DNA repair template into Sf21 insect cells through lipofection might be efficient to produce knockouts as well as knock-ins into the baculovirus. To evaluate potential application of our CRISPR/Cas9 method to improve baculovirus as protein expression vector and as biopesticide, we attempted to knockout se…